Regioselective enzymatic acylation of β-L-2′-deoxynucleosides: Application in resolution of β-D/L-2′-deoxynucleosides

Organic Letters

Volumn 6, Issue 21, 2004, Pages 3759-3762

  García, Javier ^a   Fernández, Susana ^a   Ferrero, Miguel ^a   Sanghvi, Yogesh S ^b,c   Gotor, Vicente ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b ISIS PHARMACEUTICALS   (United States)

^c RASAYAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE DERIVATIVE;

ACYLATION; ARTICLE; BURKHOLDERIA CEPACIA; ENZYME ACTIVITY; HYDROLYSIS; KINETICS; STEREOCHEMISTRY;

ACYLATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYMES; NUCLEIC ACID CONFORMATION; NUCLEOSIDES;

EID: 7044226357     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol048502v     Document Type: Article

References (37)

1. (a) Robins, R. K.; Revankar, G. R. In Antiviral Drug Development; De Clercq, E., Walker, R. T., Eds.; Plenum Press: New York, 1988; pp 11-36.
2. (b) Nucleosides and Nucleotides as Antitumor and Antiviral Agents; Chu, C. K., Baker, D. C., Eds.; Plenum Press: New York, 1993.
3. (c) MacCoss, M.; Robins, M. J. In The Chemistry of Antitumor Agents; Wilman, D. E. V., Ed.; Blackie and Sons: London, 1990; pp 261-298.
4. (d) Robins, R. K.; Kini, G. D. In The Chemistry of Antitumor Agents; Wilman, D. E. V., Ed.; Blackie and Sons: London, 1990; pp 299-321.
5. (a) Komazin, G.; Ptak, R. G.; Emmer, B. T.; Townsend, L. B.; Drach, J. C. J. Virol. 2003, 77, 11499-11506.
6. (b) Rando, R. F.; Nguyen-Ba, N. Drug Discov. Today 2000, 5, 465-476.
7. (c) Field, A. K.; Biron, K. K. Clin. Microbiol. Rev. 1994, 7, 1-13.
8. (a) Chang, C.-N.; Doong, S.-L.; Zhou, J. H.; Beach, J. W.; Jeong, L. S.; Chu, C. K.; Tasi, C.-H.; Cheng, Y.-C. J. Biol. Chem. 1992, 267, 13939-13942.
9. (b) Doong, S.-L.; Tasi, C.-H.; Schinazi, R. F.; Liotta, D. C.; Cheng, Y.-C. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 8495-8499.
10. For recent reviews: (a) Gumina, G.; Chong, Y.; Choo, H.; Song, G.-Y.; Chu, C. K. Curr. Top. Med. Chem. 2002, 2, 1065-1086. (b) Sommadossi, J.-P. In Recent Advances in Nucleosides; Chu, C. K., Ed.; Elsevier: Amsterdam, 2002; pp 417-432. (c) Lee, K.; Chu, C. K. Antimicrob. Agents Chemother. 2001, 45, 138-144. (d) Standing, D. N.; Bridges, E. G.; Placidi, L.; Faraj, A.; Loi, A. G.; Pierra, C.; Dukhan, D.; Gosselin, G.; Imbach, J.-L.; Hernández, B.; Juodawlkis, A.; Tennant, B.; Korba, B.; Cote, P.; Cretton-Scott, E.; Schinazi, R. F.; Myers, M.; Bryant, M. L.; Sommadossi, J.-P. Antivir. Chem. Chemother. 2001, 12, 119-129. (e) Gumina, G.; Song, G.-Y.; Chu, C. K. FEMS Microbiol. Lett. 2001, 202, 9-15.
11. For recent reviews: (a) Gumina, G.; Chong, Y.; Choo, H.; Song, G.-Y.; Chu, C. K. Curr. Top. Med. Chem. 2002, 2, 1065-1086. (b) Sommadossi, J.-P. In Recent Advances in Nucleosides; Chu, C. K., Ed.; Elsevier: Amsterdam, 2002; pp 417-432. (c) Lee, K.; Chu, C. K. Antimicrob. Agents Chemother. 2001, 45, 138-144. (d) Standing, D. N.; Bridges, E. G.; Placidi, L.; Faraj, A.; Loi, A. G.; Pierra, C.; Dukhan, D.; Gosselin, G.; Imbach, J.-L.; Hernández, B.; Juodawlkis, A.; Tennant, B.; Korba, B.; Cote, P.; Cretton-Scott, E.; Schinazi, R. F.; Myers, M.; Bryant, M. L.; Sommadossi, J.-P. Antivir. Chem. Chemother. 2001, 12, 119-129. (e) Gumina, G.; Song, G.-Y.; Chu, C. K. FEMS Microbiol. Lett. 2001, 202, 9-15.
12. For recent reviews: (a) Gumina, G.; Chong, Y.; Choo, H.; Song, G.-Y.; Chu, C. K. Curr. Top. Med. Chem. 2002, 2, 1065-1086. (b) Sommadossi, J.-P. In Recent Advances in Nucleosides; Chu, C. K., Ed.; Elsevier: Amsterdam, 2002; pp 417-432. (c) Lee, K.; Chu, C. K. Antimicrob. Agents Chemother. 2001, 45, 138-144. (d) Standing, D. N.; Bridges, E. G.; Placidi, L.; Faraj, A.; Loi, A. G.; Pierra, C.; Dukhan, D.; Gosselin, G.; Imbach, J.-L.; Hernández, B.; Juodawlkis, A.; Tennant, B.; Korba, B.; Cote, P.; Cretton-Scott, E.; Schinazi, R. F.; Myers, M.; Bryant, M. L.; Sommadossi, J.-P. Antivir. Chem. Chemother. 2001, 12, 119-129. (e) Gumina, G.; Song, G.-Y.; Chu, C. K. FEMS Microbiol. Lett. 2001, 202, 9-15.
13. For recent reviews: (a) Gumina, G.; Chong, Y.; Choo, H.; Song, G.-Y.; Chu, C. K. Curr. Top. Med. Chem. 2002, 2, 1065-1086. (b) Sommadossi, J.-P. In Recent Advances in Nucleosides; Chu, C. K., Ed.; Elsevier: Amsterdam, 2002; pp 417-432. (c) Lee, K.; Chu, C. K. Antimicrob. Agents Chemother. 2001, 45, 138-144. (d) Standing, D. N.; Bridges, E. G.; Placidi, L.; Faraj, A.; Loi, A. G.; Pierra, C.; Dukhan, D.; Gosselin, G.; Imbach, J.-L.; Hernández, B.; Juodawlkis, A.; Tennant, B.; Korba, B.; Cote, P.; Cretton-Scott, E.; Schinazi, R. F.; Myers, M.; Bryant, M. L.; Sommadossi, J.-P. Antivir. Chem. Chemother. 2001, 12, 119-129. (e) Gumina, G.; Song, G.-Y.; Chu, C. K. FEMS Microbiol. Lett. 2001, 202, 9-15.
14. For recent reviews: (a) Gumina, G.; Chong, Y.; Choo, H.; Song, G.-Y.; Chu, C. K. Curr. Top. Med. Chem. 2002, 2, 1065-1086. (b) Sommadossi, J.-P. In Recent Advances in Nucleosides; Chu, C. K., Ed.; Elsevier: Amsterdam, 2002; pp 417-432. (c) Lee, K.; Chu, C. K. Antimicrob. Agents Chemother. 2001, 45, 138-144. (d) Standing, D. N.; Bridges, E. G.; Placidi, L.; Faraj, A.; Loi, A. G.; Pierra, C.; Dukhan, D.; Gosselin, G.; Imbach, J.-L.; Hernández, B.; Juodawlkis, A.; Tennant, B.; Korba, B.; Cote, P.; Cretton-Scott, E.; Schinazi, R. F.; Myers, M.; Bryant, M. L.; Sommadossi, J.-P. Antivir. Chem. Chemother. 2001, 12, 119-129. (e) Gumina, G.; Song, G.-Y.; Chu, C. K. FEMS Microbiol. Lett. 2001, 202, 9-15.
15. (a) Furman, P. A.; Davis, M.; Liotta, D. C.; Paff, M.; Frick, L. W.; Nelson, D. J.; Dornsife, R. E.; Wyrster, J. A.; Wilson, L. J.; Fyfe, J. A.; Tuttle, J. V.; Miller, W. H.; Condreay, L.; Averett, D. R.; Schinazi, R. F.; Painter, G. R. Antimicrob. Agents Chemother. 1992, 36, 2686-2692.
16. (b) Schinazi, R. F.; McMillan, A.; Cannon, D.; Mathis, R.; Lloyd, R. M.; Peck, A.; Sommadossi, J.-P.; St. Clair, M.; Wilson, J.; Furman, P. A.; Painter, G. R.; Choi, W. B.; Liotta, D. C. Antimicrob. Agents Chemother. 1992, 36, 2423-2431.
17. (a) Gosselin, G.; Mathé, C.; Bergogne, M.-C.; Aubertin, A.-M.; Sommadossi, J.-P.; Schinazi, R.; Imbach, J.-L. Nucleosides Nucleotides 1995, 14, 611-617.
18. (b) Mansuri, M. M.; Farina, V.; Starrett, J. E., Jr.; Benigni, D. A.; Brankovan, V.; Martin, J. C. Bioorg. Med. Chem. Lett. 1991, 1, 65-68.
19. Lin, T.-S.; Luo, M.-Z.; Liu, M.-C.; Zhu, Y.-L.; Gullen, E.; Dutschman, G. E.; Cheng, Y.-C. J. Med. Chem. 1996, 39, 1757-1759.
20. (a) Van Draanen, N. A.; Tisdale, N.; Parry, N. R.; Jansen, R.; Dornsife, R. E., Tuttle, J. V.; Averett, D. R.; Koszalka, G. W. Antimicrob. Agents Chemother. 1994, 38, 868-871.
21. (b) Lin, T.-S.; Luo, M.-Z.; Liu, M.-C.; Pai, S. B.; Dutschman, G. E.; Cheng, Y.-C. J. Med. Chem. 1994, 37, 798-803.
22. Chu, C. K.; Ma, T. W.; Schanmuganathan, K.; Wang, C-G.; Xiang, Y.-J.; Pai, S. B.; Yao, G.-Q.; Sommadossi, J.-P.; Cheng, Y.-C. Antimicrob. Agents Chemother. 1995, 39, 979-981.
23. Grove, K. L.; Guo, X.; Liu, S.-H.; Gao, Z.; Chu, C. K.; Cheng, Y.-C. Cancer Res. 1995, 55, 3008-3011.
24. Nolte, A.; Klussmann, S.; Bald, R.; Erdmann, V. A.; Fürste, J. P. Nat. Biotechnol. 1996, 14, 1116-1119.
25. Albert, M.; De Souza, D.; Feiertag, P.; Hönig, H. Org. Lett. 2002, 4, 3251-3254.
26. Shimizu, B.; Asai, M.; Hieda, H.; Miyaki, M.; Okazabi, H. Chem. Pharm. Bull. 1965, 13, 616-618.
27. For reviews on enzymatic transformations in nucleosides, see: (a) Ferrero, M.; Gotor, V. Chem. Rev. 2000, 100, 4319-4347. (b) Ferrero, M.; Gotor, V. Monatsh. Chem. 2000, 131, 585-616.
28. For reviews on enzymatic transformations in nucleosides, see: (a) Ferrero, M.; Gotor, V. Chem. Rev. 2000, 100, 4319-4347. (b) Ferrero, M.; Gotor, V. Monatsh. Chem. 2000, 131, 585-616.
29. García, J.; Fernández, S.; Ferrero, M.; Sanghvi, Y. S.; Gotor, V. Tetrahedron: Asymmetry 2003, 14, 3533-3540.
30. For related papers: (a) García, J.; Fernández, S.; Ferrero, M.; Sanghvi, Y. S.; Gotor, V. Tetrahedron Lett. 2004, 45, 1709-1712. (b) García, J.; Fernández, S.; Ferrero, M.; Sanghvi, Y. S.; Gotor, V. Nucleosides Nucleotides Nucleic Acids 2003, 22, 1455-1457. (c) García, J.; Fernández, S.; Ferrero, M.; Sanghvi, Y. S.; Gotor, V. J. Org. Chem. 2002, 67, 4513-4519.
31. For related papers: (a) García, J.; Fernández, S.; Ferrero, M.; Sanghvi, Y. S.; Gotor, V. Tetrahedron Lett. 2004, 45, 1709-1712. (b) García, J.; Fernández, S.; Ferrero, M.; Sanghvi, Y. S.; Gotor, V. Nucleosides Nucleotides Nucleic Acids 2003, 22, 1455-1457. (c) García, J.; Fernández, S.; Ferrero, M.; Sanghvi, Y. S.; Gotor, V. J. Org. Chem. 2002, 67, 4513-4519.
32. For related papers: (a) García, J.; Fernández, S.; Ferrero, M.; Sanghvi, Y. S.; Gotor, V. Tetrahedron Lett. 2004, 45, 1709-1712. (b) García, J.; Fernández, S.; Ferrero, M.; Sanghvi, Y. S.; Gotor, V. Nucleosides Nucleotides Nucleic Acids 2003, 22, 1455-1457. (c) García, J.; Fernández, S.; Ferrero, M.; Sanghvi, Y. S.; Gotor, V. J. Org. Chem. 2002, 67, 4513-4519.
33. (a) Reese, C. B.; Yan, H. J. Chem. Soc., Perkin Trans. 1 2002, 2619-2633.
34. (b) Reese, C. B.; Song, Q. Nucleic Acids Res. 1999, 27, 963-971.
35. (c) Reese, C. B.; Song, Q. Bioorg. Med. Chem. Lett. 1997, 7, 2787-2792.
36. Purchased from ChemGenes Corporation, Wilmington, MA; www.chemgenes.com.
37. For a review of the parallel kinetic resolution of racemic mixtures, see: Dehli, J. R.; Gotor, V. Chem. Soc. Rev. 2002, 31, 365-370.